PUBLISHER: The Business Research Company | PRODUCT CODE: 1942707
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942707
Diabetes treatment devices are specialized medical tools designed to help individuals manage and treat diabetes by monitoring blood sugar levels, administering insulin, or addressing related health concerns. These devices play a crucial role in helping patients achieve optimal blood glucose control and prevent complications linked to diabetes.
The primary types of diabetes treatment devices include blood glucose monitoring devices, self-monitoring tools, blood glucose meters, testing strips, lancets, continuous glucose monitoring devices, sensors, transmitters, receivers, and other related equipment. Blood glucose monitoring devices are essential for measuring blood sugar levels, assisting individuals in effectively managing their diabetes. These devices are available through various distribution channels, including hospital pharmacies, retail pharmacies, diabetes clinics, institutional sales, and online pharmacies. They cater to a wide range of users, such as hospitals, homecare settings, diagnostic centers, ambulatory surgery centers, and other healthcare facilities.
Tariffs are impacting the diabetes treatment devices market by increasing the cost of imported sensors, transmitters, and smart insulin delivery devices. Segments such as continuous glucose monitoring devices and smart insulin pumps are most impacted, particularly in regions like Asia-Pacific and North America that rely heavily on imports. This has led to higher device prices and potential supply chain delays. However, tariffs have also encouraged local manufacturing, investment in domestic production facilities, and development of cost-optimized devices for regional markets.
The diabetes treatment devices market research report is one of a series of new reports from The Business Research Company that provides diabetes treatment devices market statistics, including diabetes treatment devices industry global market size, regional shares, competitors with a diabetes treatment devices market share, detailed diabetes treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes treatment devices industry. This diabetes treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diabetes treatment devices market size has grown strongly in recent years. It will grow from $12.34 billion in 2025 to $13.11 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to reliance on traditional blood glucose meters, limited awareness of self-monitoring devices, growing hospital and diagnostic center infrastructure, increasing prevalence of diabetes, adoption of standard lancets and testing strips.
The diabetes treatment devices market size is expected to see strong growth in the next few years. It will grow to $16.53 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to development of smart insulin pens and pumps, rising adoption of real-time continuous glucose monitoring, integration with smartphones and wearable devices, increasing remote patient monitoring programs, expansion of diabetes clinics and online distribution channels. Major trends in the forecast period include rising adoption of continuous glucose monitoring devices, increasing preference for smart insulin delivery systems, growth in homecare and remote patient monitoring, expansion of wearable and handheld glucometers, rising demand for safety-enhanced lancets and testing strips.
The rising obesity rates are anticipated to drive the expansion of the diabetes treatment devices market in the coming years. Obesity rate indicates the proportion of individuals identified as obese based on their body mass index (BMI). The surge in obesity is largely attributed to unhealthy diets rich in calories, sugars, and fats, which result in excessive weight gain when not offset by physical activity. Diabetes treatment devices contribute to lowering obesity rates by supporting improved blood sugar management, which encourages healthier lifestyle practices and effective weight control. For example, in September 2024, the US Centers for Disease Control and Prevention (CDC), a national public-health agency in the US, reported that adult obesity rates reached 35% or higher in 23 US states in 2023, up from 22 states in 2022, reflecting a worsening obesity trend. As a result, the increasing obesity rates are fueling growth in the diabetes treatment devices market.
Major companies in the diabetes treatment devices market are increasingly focusing on integrating advanced automation technologies, such as automated insulin delivery algorithms, to improve treatment accuracy and continuous glycemic management. These algorithms leverage real-time glucose data from continuous glucose monitoring sensors to automatically modify basal insulin dosing, aiding in maintaining glucose levels within the desired range with minimal manual effort. For example, in April 2023, Medtronic plc, a US-based medical technology firm, obtained FDA approval for the MiniMed 780G System, an automated insulin delivery solution designed for people with type 1 diabetes. This system automatically corrects high glucose levels and adjusts insulin delivery every five minutes. It includes SmartGuard technology for real-time glucose-responsive insulin adjustments, Bluetooth connectivity for mobile monitoring, and integrated support for continuous glucose monitoring. The MiniMed 780G System enhances treatment precision, glucose stability, and overall day-to-day diabetes management outcomes.
In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical for an undisclosed sum. This acquisition enables Abbott Laboratories to combine continuous glucose monitoring with smart insulin dosing technology, aiming to deliver more personalized, connected, and accessible diabetes care. Bigfoot Biomedical Inc. is a US-based medical technology company that specializes in developing and providing diabetes treatment devices.
Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care
North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the diabetes treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The diabetes treatment devices market consists of sales of smart insulin pens, artificial pancreas systems, closed-loop systems, and jet injectors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diabetes Treatment Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses diabetes treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for diabetes treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes treatment devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.